Skip to Content
Merck
  • A random six-phase switch regulates pneumococcal virulence via global epigenetic changes.

A random six-phase switch regulates pneumococcal virulence via global epigenetic changes.

Nature communications (2014-10-01)
Ana Sousa Manso, Melissa H Chai, John M Atack, Leonardo Furi, Megan De Ste Croix, Richard Haigh, Claudia Trappetti, Abiodun D Ogunniyi, Lucy K Shewell, Matthew Boitano, Tyson A Clark, Jonas Korlach, Matthew Blades, Evgeny Mirkes, Alexander N Gorban, James C Paton, Michael P Jennings, Marco R Oggioni
ABSTRACT

Streptococcus pneumoniae (the pneumococcus) is the world's foremost bacterial pathogen in both morbidity and mortality. Switching between phenotypic forms (or 'phases') that favour asymptomatic carriage or invasive disease was first reported in 1933. Here, we show that the underlying mechanism for such phase variation consists of genetic rearrangements in a Type I restriction-modification system (SpnD39III). The rearrangements generate six alternative specificities with distinct methylation patterns, as defined by single-molecule, real-time (SMRT) methylomics. The SpnD39III variants have distinct gene expression profiles. We demonstrate distinct virulence in experimental infection and in vivo selection for switching between SpnD39III variants. SpnD39III is ubiquitous in pneumococci, indicating an essential role in its biology. Future studies must recognize the potential for switching between these heretofore undetectable, differentiated pneumococcal subpopulations in vitro and in vivo. Similar systems exist in other bacterial genera, indicating the potential for broad exploitation of epigenetic gene regulation.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Erythromycin standard solution, 1 mg/mL in H2O
Sigma-Aldrich
Erythromycin, potency: ≥850 μg per mg
USP
Erythromycin, United States Pharmacopeia (USP) Reference Standard
Erythromycin, for microbiological assay, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Erythromycin, tested according to Ph. Eur.
Supelco
Erythromycin, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Erythromycin, meets USP testing specifications
Sigma-Aldrich
Erythromycin, BioReagent, suitable for cell culture
Sigma-Aldrich
Chloramphenicol, BioReagent, suitable for plant cell culture
Sigma-Aldrich
Chloramphenicol, ≥98% (HPLC)
Sigma-Aldrich
Chloramphenicol, meets USP testing specifications
Chloramphenicol, European Pharmacopoeia (EP) Reference Standard
Supelco
Chloramphenicol, VETRANAL®, analytical standard